Home Mf Research Icici Prudential Pharma Healthcare And Diagnostics Phd Fund Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI
Fund info
NAV (as on 2025-07-18)
40.50 -0.52%
AUM (Fund Size)
41
Expense Ratio
1.91%
Exit load
N/A
Risk
Very High
AMC
ICICI Prudential Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-07-11 ₹1,000.00 ₹1,016.31
1.63 %
Two Week 2025-07-03 ₹1,000.00 ₹1,018.87
1.89 %
One Month 2025-06-18 ₹1,000.00 ₹1,046.51
4.65 %
Three Months 2025-04-21 ₹3,000.00 ₹3,203.84
6.79 %
Six Months 2025-01-20 ₹6,000.00 ₹6,518.60
8.64 %
One Year 2024-07-18 ₹12,000.00 ₹13,046.29
8.72 %
Three Year 2022-07-19 ₹36,000.00 ₹56,570.90
57.14 %
Five Year 2020-07-20 ₹60,000.00 ₹109,795.50
82.99 %
Since Inception 2018-07-13 ₹86,000.00 ₹209,603.13
143.72 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity 79%
Debt 2%
Others N/A

Sectors Holding in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

Pharmaceuticals & Biotechnology
69%
Healthcare Services
5%
Retailing
1%
It - Services
1%
Insurance
2%
Chemicals & Petrochemicals
1%
Healthcare Equipment & Supplies
0%
Other
2%

Companies Holding in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

Sun Pharmaceutical Industries Ltd.
12.66%
Dr. Reddy's Laboratories Ltd.
9.66%
Divi's Laboratories Ltd.
9.03%
Cipla Ltd.
7.85%
Aurobindo Pharma Ltd.
6.34%
Alkem Laboratories Ltd.
4.12%
Zydus Lifesciences Ltd.
4.01%
Lupin Ltd.
3.98%
Gland Pharma Ltd.
3.95%
Syngene International Ltd.
2.46%
Pfizer Ltd.
2.27%
Alembic Pharmaceuticals Ltd.
1.99%
Apollo Hospitals Enterprise Ltd.
1.79%
Medplus Health Services Ltd
1.64%
Mankind Pharma Ltd
1.62%
Biocon Ltd.
1.62%
Shilpa Medicare Ltd.
1.58%
Sagility India Ltd
1.44%
Thyrocare Technologies Ltd.
1.42%
Advanced Enzyme Technologies Ltd.
1.42%
Windlas Biotech Ltd.
1.42%
Medi Assist Healthcare Services Ltd
1.36%
Aarti Drugs Ltd.
1.28%
Fine Organic Industries Ltd.
1.28%
Star Health & Allied Insurance
1.27%
Sun Pharma Advanced Research Co. Ltd
1.16%
Yatharth Hospital & Trauma Care Services Pvt Ltd
1.07%
Sanofi Consumer Healthcare India Ltd
1.01%
Glenmark Pharmaceuticals Ltd.
1.00%
Aarti Industries Ltd.
0.98%
FDC Ltd.
0.95%
Procter & Gamble Health Ltd.
0.81%
Astrazeneca Pharma India Ltd.
0.80%
Emcure Pharmaceuticals Ltd.
0.72%
Senores Pharmaceuticals Ltd
0.61%
Unichem Laboratories Ltd.
0.26%
Laxmi Dental Ltd.
0.14%
Laxmi Organic Industries Ltd.
0.01%
TREPS
2.90%
Cash Margin - Derivatives
0.15%
Net Current Assets
-0.04%

Risk Ratios

Std. Deviation N/A
Beta N/A
Sharpe Ratio N/A
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Risk-O-Meter

Investors understand that their principal will be at
Very High

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
1.91
Expense Ratio Direct
1.07
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?